Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss

iRhythm misled investors by promoting Zio AT as a real-time monitor for high-risk patients, inflating stock prices that dropped when the truth emerged.